Invasive diagnostic techniques in idiopathic interstitial pneumonias

Respirology

Volumn 21, Issue 1, 2016, Pages 44-50

  Poletti, Venerino ^a,d   Ravaglia, Claudia ^a   Gurioli, Carlo ^a   Piciucchi, Sara ^a   Dubini, Alessandra ^a   Cavazza, Alberto ^b   Chilosi, Marco ^c   Rossi, Andrea ^c   Tomassetti, Sara ^a  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

bronchoscopy and interventional techniques; interstitial lung disease

Indexed keywords

BIOPSY TECHNIQUE; ENDOBRONCHIAL ULTRASONOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; IMAGE GUIDED BIOPSY; INTERMETHOD COMPARISON; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; PRIORITY JOURNAL; REVIEW; TRANSBRONCHIAL BIOPSY; TRANSBRONCHIAL CRYOBIOPSY; TRANSTHORACIC BIOPSY; BIOPSY; IDIOPATHIC INTERSTITIAL PNEUMONIAS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

BIOPSY; BRONCHOALVEOLAR LAVAGE; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; IDIOPATHIC PULMONARY FIBROSIS; LUNG;

EID: 84951163354     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12694     Document Type: Review

References (57)

1. Poletti V, Chilosi M, Olivieri D,. Diagnostic invasive procedures in diffuse infiltrative lung diseases. Respiration 2004; 71: 107-119.
2. Antin-Ozerkis D,. Interstitial lung disease: a clinical overview and general approach. In:, Grippi MA, Elias JA, Fishman JA, Kotloff RM, Pack AI, Senior RM, (eds) Fishman's Pulmonary Diseases and Disorders, Vol. I. McGraw Hill, New York, 2015; 810-822.
3. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, et al. An official American Thoracic Society/European Respiratory Society Statement: update of the International Multidisciplinary Classification of Idiopathic Interstitial Pneumonias. Am. J. Respir. Crit. Care Med. 2013; 188: 733-748.
4. Poletti V, Casoni GL, Gurioli G, Ryu JH, Tomassetti S,. Lung cryobiopsies: a paradigm shift in diagnostic bronchoscopy. Respirology 2014; 19: 645-654.
5. Casoni GL, Tomassetti S, Cavazza A, Colby TV, Dubini A, Ryu JH, Carretta E, Tantalocco P, Piciucchi S, Ravaglia C, et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS ONE 2014; 9: e86716.
6. Annema JT, Rabe KF,. State of the art lectures: EUS and EBUS in pulmonary medicine. Endoscopy 2006; 38: S118-122.
7. Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur. Respir. J. 2015; 46: 976-987.
8. Jacob J, Hansell DM,. HRCT of fibrosing lung disease. Respirology 2015; 20: 859-872.
9. Romagnoli M, Nannini C, Piciucchi S, Girelli F, Gurioli C, Casoni G, Ravaglia C, Tomassetti S, Gurioli C, Gavelli G, et al. Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Eur. Respir. J. 2011; 38: 384-391.
10. Watadani T, Sakai F, Johkoh T, Noma S, Akira M, Fujimoto K, Bankier AA, Lee KS, Müller NL, Song JW, et al. Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology 2013; 266: 936-944.
11. Poletti V, Benzaquen S,. Transbronchial cryobiopsy in diffuse parenchymal lung disease. A new star in the horizon. Sarcoidosis Vasc. Diffuse Lung Dis. 2014; 31: 178-181.
12. Mark DB, Wong JB,. Decision-making in clinical medicine. In:, Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo L, (eds) Harrison's Principles of Internal Medicine. Mc Graw Hill, New York, 2015; 18-26.
13. Chilosi M, Carloni C, Rossi A, Poletti V,. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema. Transl. Res. 2013; 162: 156-173.
14. Hambly N, Shimbori C, Kolb M,. Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers. Respirology 2015; 20: 1010-1022.
15. Ryu JH, Olson EJ, Midthun DE, Swensen SJ,. Diagnostic approach to the patient with diffuse lung disease. Mayo Clin. Proc. 2002; 77: 1221-1227.
16. Oshimo S, Bonella F, Cui A, Beume M, Kohno N, Guzman J, Costabel U,. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 179: 1043-1047.
17. Kawabata Y, Takemura T, Hebisawa A, Ogura T, Yamaguchi T, Kuriyama T, Nagai S, Sakatani M, Chida K, Sakai F, et al. Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia. Histopathology 2008; 52: 194-202.
18. Costabel U,. CD4/CD8 ratios in bronchoalveolar lavage fluid: of value for diagnosing sarcoidosis? Eur. Respir. J. 1997; 10: 2699-2700.
19. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am. J. Respir. Crit. Care Med. 2012; 185: 1004-1014.
20. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788-824.
21. Poletti V, Romagna M, Gasponi A, Baruzzi G, Allen KA,. Bronchoalveolar lavage in the diagnosis of low-grade, MALT type B-cell lymphoma in the lung. Monaldi Arch. Chest Dis. 1995; 50: 191-194.
22. Poletti V, Patelli M, Poletti G, Bertanti T, Spiga L,. Diffuse panbronchiolitis observed in an Italian. Chest 1990; 98: 515-516.
23. Poletti V, Poletti G, Murer B, Saragoni L, Chilosi M,. Bronchoalveolar lavage in malignancy. Semin. Respir. Crit. Care Med. 2007; 28: 534-545.
24. Ryu JH, Mooua T, Daniels CE, Hartman TE, Yi ES, Utz JP, Limper AH,. Idiopathic pulmonary fibrosis: evolving concepts. Mayo Clin. Proc. 2014; 89: 1130-1142.
25. Andersen HA, Fontana RS, Harrison EG Jr,. Transbronchoscopic lung biopsy in diffuse pulmonary disease. Dis. Chest 1965; 48: 187-192.
26. Leslie KO, Gruden JF, Parish JM, Scholand MB,. Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch. Pathol. Lab. Med. 2007; 131: 407-423.
27. Poletti V, Patelli M, Poggi S, Bertanti T, Spiga L, Ferracini R,. Transbronchial lung biopsy and bronchoalveolar lavage in diagnosis of diffuse infiltrative lung diseases. Respiration 1988; 54: 66-72.
28. Berbescu EA, Katzenstein AL, Snow JL, Zisman DA,. Transbronchial biopsy in usual interstitial pneumonia. Chest 2006; 129: 1126-1131.
29. Tomassetti S, Cavazza A, Colby TV, Ryu JH, Nanni O, Scarpi E, Tantalocco P, Buccioli M, Dubini A, Piciucchi S, et al. Transbronchial biopsy is useful in predicting UIP pattern. Respir. Res. 2012; 13: 96.
30. Facciolongo N, Patelli M, Gasparini S, Lazzari Agli L, Salio M, Simonassi C, Del Prato B, Zanoni P,. Incidence of complications in bronchoscopy. Multicentre prospective study of 20 986 bronchoscopies. Monaldi Arch. Chest Dis. 2009; 71: 8-14.
31. Poletti V, Hetzel J,. Transbronchial cryobiopsy in diffuse parenchymal lung diseases: need of procedural standardization. Respiration 2015; 90: 275-278.
32. Tomassetti S, Wells AU, Costabel U, Cavazza A, Colby TV, Rossi G, Sverzellati N, Carloni A, Carretta E, Buccioli M, et al. The impact of bronchoscopic lung cryobiopsy in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2015 (in press).
33. Casoni GL, Gurioli G, Chhajed PN, Chilosi M, Zompatori M, Olivieri D, Poletti V,. The value of transbronchial lung biopsy using jumbo forceps via rigid bronchoscope in diffuse lung disease. Monaldi Arch. Chest Dis. 2008; 69: 59-64.
34. Trisolini R, Lazzari Agli L, Tinelli C, DDe Silvestri A, Scotti V, Patelli M,. Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosis of sarcoidosis in clinically unselected study populations. Respirology 2015; 20: 226-234.
35. Fritscher-Ravens A, Sriram PV, Bobrowski C, Pforte A, Topalidis T, Krause C, Jaeckle S, Thonke F, Soehendra N,. Mediastinal lymphadenopathy in patients with or without previous malignancy: EUS-FNA-based differential cytodiagnosis in 153 patients. Am. J. Gastroenterol. 2000; 95: 2278-2284.
36. Moonim MT, Breen R, Fields PA, Santis G,. Diagnosis and subtyping of de novo and relapsed mediastinal lymphomas by endobronchial ultrasound needle aspiration. Am. J. Respir. Crit. Care Med. 2013; 188: 1216-1223.
37. Tomlinson GS, Thomas N, Chain BM, Best K, Simpson N, Hardavella G, Brown J, Bhowmik A, Navani N, Janes SM, et al. Transcriptional profiling of endobronchial ultrasound guided lymph node samples aids diagnosis of mediastinal lymphoadenopathy. Chest 2015. doi: 10.1378/chest.15-0647
38. Conti V, Gurioli C, Rossi A, Casoni GL, Piciucchi S, Dubini A, Chilosi M, Poletti V,. Value of transesophageal ultrasound (EUS)-guided fine needle aspiration (FNA) in the diagnosis of Lymphomatoid Granulomatosis: a case report. Rass. Patol. App. Respir., fascicolo 1/2015.
39. Bonifazi M, Zuccatosta L, Trisolini R, Moja L, Gasparini S,. Transbronchial needle aspiration: a systematic review on predictors of a successful aspirate. Respiration 2013; 86: 123-134.
40. Niimi H, Kang EY, Kwong JS, Carignan S, Muller NL,. CT of chronic infiltrative lung disease: prevalence of mediastinal lymphoadenopathy. J. Comput. Assist. Tomogr. 1996; 20: 305-308.
41. Tomassetti S, Gurioli C, Ryu JH, Decker PA, Ravaglia C, Tantalocco P, Buccioli M, Piciucchi S, Sverzellati N, Dubini A, et al. The impact of lung cancer on survival of idiopathic pulmonary fibrosis. Chest 2015; 147: 157-164.
42. Choi SH, Chae EJ, Kim JE, Kim EY, Oh SY, Hwang HJ, Lee HJ,. Percutaneous CT-guided aspiration and core biopsy of pulmonary nodules smaller than 1 cm: analysis of outcomes of 305 procedures from a tertiary referral center. AJR 2013; 201: 964-970.
43. Miao L, Wang Y, Li Y, Ding J, Chen L, Dai J, Cai H, Xiao Y, Cao M, Huang M, et al. Lesion with morphologic feature of organizing pneumonia (OP) in CT-guided lung biopsy samples for diagnosis of bronchiolitis obliterans organizing pneumonia (BOOP): a retrospective study of 134 cases in a single center. J. Thorac. Dis. 2014; 6: 1251-1260.
44. Kondoh Y, Taniguchi H, Kitaichi M, Yokoi T, Johkoh T, Oishi T, Kimura T, Nishiyama O, Kato K, du Bois RM,. Acute exacerbation of interstitial pneumonia following surgical lung biopsy. Respir. Med. 2006; 100: 1753-1759.
45. Utz JP, Ryu JH, Douglas WW, Hartman TE, Tazelaar HD, Myers JL, Allen MS, Schroeder DR,. High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur. Respir. J. 2001; 17: 175-179.
46. Nguyen W, Myer KC,. Surgical lung biopsy for the diagnosis of interstitial lung disease: a review of the literature and recommendations for optimizing safety and efficacy. Sarcoidosis Vasc. Diffuse Lung Dis. 2013; 30: 3-16.
47. Han Q, Luo Q, Xie JX, Wu LL, Liao LY, Zhang XX, Chen RC,. Diagnostic yield and postoperative mortality associated with surgical lung biopsy for evaluation of interstitial lung diseases: a systematic review and a meta-analysis. J. Thorac. Cardiovasc. Surg. 2015; 149: 1394-1401.
48. Pompeo E, Rogliani P, Cristino B, Schillaci O, Novelli G, Saltini C,. Awake thoracoscopic biopsy of interstitial lung disease. Ann. Thorac. Surg. 2013; 95: 445-452.
49. Kim SY, Diggans J, Pankratz D, Huang J, Pagan M, Sindy N, Tom E, Anderson J, Choi Y, Lynch DA, et al. Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data. Lancet Respir. Med. 2015; 3: 473-482.
50. Jenkins RG, Simpson JK, Saini G, Bentley JH, Russell AM, Braybrooke R, Molyneaux PL, McKeever TM, Wells AU, Flynn A, et al. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study. Lancet Respir. Med. 2015; 3: 462-472.
51. Wells A, Costabel U, Poletti V, Crestani B, Egan J, Margaritopoulos G, Antoniou K,. Challenges in IPF diagnosis, current management and future perspectives. Sarcoidosis Vasc. Diffuse Lung Dis. 2015; 32: 28-35.
52. Kropski JA, Blackwell TS, Loyd JE,. The genetic basis of idiopathic pulmonary fibrosis. Eur. Respir. J. 2015; 45: 1717-1727.
53. Gruden JF, Panse PM, Leslie KO, Tazelaar HD, Colby TV,. UIP diagnosed at surgical lung biopsy, 2000-2009: HRCT patterns and proposed classification system. AJR 2013; 200: W458-467.
54. Chilosi M, Poletti V, Rossi A,. The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir. Res. 2012; 13: 3.
55. Lam AP, Herazo-Maya JD, Sennello JA, Flozak AS, Russell S, Mutlu GM, Budinger GR, DasGupta R, Varga J, Kaminski N, et al. Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2014; 190: 185-195.
56. Alder JK, Barkauskas CE, Limjunyawong N, Stanley SE, Kembou F, Tuder RM, Hogan BL, Mitzner W, Armanios M,. Telomere dysfunction causes alveolar stem cell failure. Proc. Natl. Acad. Sci. U.S.A. 2015; 112: 5099-5104.
57. Kaunisto J, Kelloniemi K, Sutinen E, Hodgson U, Piilonen A, Kaarteenaho R, Mäkitaro R, Purokivi M, Lappi-Blanco E, Saarelainen S, et al. Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis. BMC Pulm. Med. 2015; 15: 92.